PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Bluejay Diagnostics, Inc.
Filed: July 5, 2024
Period of Report: July 5, 2024
Accession Number: 0001213900-24-059565

View Document ↗ View on SEC.gov ↗